Nonstandard abbreviations: CA 125, cancer antigen 125
; HE4, human epididymis protein 4; NSCLC, non-small cell lung cancer; SCLC, small cell lung cancer.
 Nonstandard abbreviations: CA125, cancer antigen 125
; ITIH4, inter-[alpha]-trypsin inhibitor heavy chain 4; CTAP3, connective tissue-activating peptide III; FDA, US Food and Drug Administration; IDE, investigational device exemption.
Cancer antigen 125
associated with multiple benign and malignant pathologies.
TATI (tumor associated trypsin inhibitor) and cancer antigen 125
(CA 125) in patients with early-stage endometrial cancer.
In contrast, we observed false-positive values for the cancer antigen 125
(CA 125), because of HAMA Interferences in samples from ovarian cancer patients treated with the anti-CA-125 antibody OC125, which could be corrected by preincubation with mouse IgG but not with MAK33 (4).
This was vastly superior to the 35% positive predictive value in the same samples of cancer antigen 125
, the present gold standard clinical biomarker.
A case of benign multicystic mesothelioma of the peritoneum (BMMP) is presented uniquely characterized by an elevated serum carbohydrate antigen 19-9 (CA-19-9) and biopsy positive immunostaining for CA-19-9, carcinoembryonic antigen (CEA), and cancer antigen 125
Further testing protocols include at least a yearly transvaginal ultrasound scan and a serum cancer antigen 125
(CA 125) test.
The cut-off values for the tumor markers (according to the biochemistry laboratory in our hospital) were 0.5 IU/L for Human Chorionic Gonadotrpin (HCG), 35 U/mL for Cancer Antigen 125
(CA125), 37 U/mL for CA 19-9, 7 U/mL for alpha-fetoprotein (AFP) and 214 U/L for lactate dehydrogenase (LDH).
A-125 (cancer antigen 125
, carcinoma antigen 125, or carbohydrate antigen 125) also known as mucin 16 or MUC16 is a protein that in humans is encoded by the MUC16 gene.
The authors based the model on a panel of selected circulating protein biomarkers (cancer antigen 125
[CA125], carcinoembryonic antigen [CEA], cytokeratin-19 fragment [CYFRA 21-1], and the precursor form of surfactant protein B [Pro-SFTPB]) and compared its performance to a traditional risk prediction model and current U.S.
"Screening with cancer antigen 125
(CA-125) and transvaginal sonography (TVS) appears practical, but establishing the value of screening is challenging," they said.
The cancer antigen 125
level was high (280.7 IU/ml).
In fact, however, when average-risk women undergo screening--such as with transvaginal ultrasonography or a cancer antigen 125
(CA 125) test--many of those with abnormal results may undergo unnecessary surgery and experience resultant potential harm.
Cancer antigen 125
(CA-125) is a biomarker usually expressed at the atypical surface of the coelomic epithelium.